These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 31537337)
21. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. Greenspon AJ; Patel JD; Lau E; Ochoa JA; Frisch DR; Ho RT; Pavri BB; Kurtz SM J Am Coll Cardiol; 2011 Aug; 58(10):1001-6. PubMed ID: 21867833 [TBL] [Abstract][Full Text] [Related]
22. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648 [TBL] [Abstract][Full Text] [Related]
23. Impact of delayed device re-implantation on outcomes of patients with cardiovascular implantable electronic device related infective endocarditis. Arshad V; Baddour LM; Lahr BD; Khalil S; Tariq W; Talha KM; Cha YM; DeSimone DC; Sohail MR Pacing Clin Electrophysiol; 2021 Aug; 44(8):1303-1311. PubMed ID: 34132396 [TBL] [Abstract][Full Text] [Related]
24. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500 [TBL] [Abstract][Full Text] [Related]
25. Management of bacteremia in patients living with cardiovascular implantable electronic devices. DeSimone DC; Sohail MR Heart Rhythm; 2016 Nov; 13(11):2247-2252. PubMed ID: 27546815 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors. Han HC; Hawkins NM; Pearman CM; Birnie DH; Krahn AD Europace; 2021 Jun; 23(23 Suppl 4):iv3-iv10. PubMed ID: 34051086 [TBL] [Abstract][Full Text] [Related]
28. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection. Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666 [TBL] [Abstract][Full Text] [Related]
29. Incidence and risk factors for cardiac implantable electronic device infection in current clinical settings in a Japanese population: A 20-year single-center observational study. Ishiguchi H; Ishikura M; Yoshida M; Imoto K; Sonoyama K; Kawabata T; Ishihara Y; Yoshiga Y; Shimizu A; Oda T J Cardiol; 2020 Jul; 76(1):115-122. PubMed ID: 32037251 [TBL] [Abstract][Full Text] [Related]
32. Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality. Tarakji KG; Wilkoff BL Expert Rev Cardiovasc Ther; 2013 May; 11(5):607-16. PubMed ID: 23621142 [TBL] [Abstract][Full Text] [Related]
33. Trends in the 30-year span of noninfectious cardiovascular implantable electronic device complications in Olmsted County. Kowlgi GN; Vaidya V; Dai MY; Futela P; Mishra R; Hodge DO; Deshmukh AJ; Mulpuru SK; Friedman PA; Cha YM Heart Rhythm O2; 2024 Mar; 5(3):158-167. PubMed ID: 38560372 [TBL] [Abstract][Full Text] [Related]